🇺🇸 FDA
Pipeline program

GSPE

2010GGC10294

Phase 2 small_molecule completed

Quick answer

GSPE for Atherosclerosis of Arteries of the Extremities, Unspecified is a Phase 2 program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Atherosclerosis of Arteries of the Extremities, Unspecified
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials